Apollo Hospitals on Thursday reported a 25% year-on-year rise in consolidated net profit to Rs 494 crore for the second quarter. The profit was driven by revenue growth across healthcare, pharmacy and digital health business.
Consolidated revenue from operations increased 13% to Rs 6,304 crore during the quarter. Consolidated Ebitda rose 15% to Rs 941 crore, with margins improving to 14.93% from 14.59% a year earlier.
Core healthcare (hospital) revenues grew 9% to Rs 3,169 crore, though bed occupancy slipped to 69% from 73% in the same quarter last year. The company attributed the dip to a higher incidence of seasonal admissions in the corresponding period last year.
As of September, Apollo operated 8,050 beds across its network (excluding Apollo Health & Lifestyle and managed beds). Apollo plans to add 4,400 capacity beds and 3,600 census beds over the next five years, with an investment of `5,800 crore funded through internal accruals.
Its diagnostics and retail health arm, AHLL, reported a 9% rise in revenue to Rs 474 crore, while the digital health and pharmacy distribution vertical, HealthCo, recorded a 17% increase to Rs 2,661 crore.